Fig. 3From: Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablationGadobenate dimeglumine–enhanced axial MRI scans in a 57-year-old man with hepatitis B virus (A-H). A 1.7-cm steatotic mass is detected in segments VII. The mass shows T1 hypointensity (A), signal intensity reduced on out-of-phase TIWI (arrow in B), moderate T2 hyperintensity (C), marked hyperintensity on DWI (b = 1000 s/mm2) (D), rim enhancement on arterial phase image (E), “wash-out” appearance on portal venous phase (F) and equilibrium phase (G), marked hepatobiliary phase hypointensity (H). The recurrence-free survival for this patient was 150 daysBack to article page